Embed Size (px)
doi:10.1016/S0006-2952(12)00808-8
BIOCHEMICAL PHARMACOLOGY
Editor-in-Chief: S.J. Enna, University of Kansas, USA
Editors: J.G. Piette, University of Liège, Belgium K. Mullane, Profectus Pharma Consulting Inc., USA
Commentary Editor: M. Williams, Northwestern University, USA
Biochemical Pharmacology Editorial Office:University of Kansas Medical Center
3901 Rainbow Boulevard, Mail Stop 4016, Kansas City, Kansas 66160, USA Tel: +1-913-588-7533, Fax: +1-913-588-7373, E-mail: [email protected]
Antibiotics & ChemotherapeuticsB.B. Aggarwal, Houston, TX, USAR. Alfi eri, Parma, ItalyC. Bailly, Toulouse, FranceE. A. Bey, Morgantown, WV, USAS. Ceruti, Milano, ItalyB.S. Cummings, Athens, GA, USAM. Davies, Houston, TX, USAE. De Clercq, Leuven, BelgiumM. Diederich, Luxembourg, LuxembourgJ.-D. Docquier, Siena, ItalyM. Galleni, Liège, BelgiumHP. Gerber, NY, USAR. Ghosh, San Antonio, TX, USAC. Giardina, Storrs, CT, USAO. Handa, Kyoto, JapanK. Kashfi , New York, NY, USAF.A.E. Kruyt, Groningen, NetherlandsI. Marzo, Zaragoza, SpainC. Michiels, Namur, BelgiumJ. Neyts, Leuven, BelgiumS. Nock, Redwood City, CA, USAB.A. Ruggeri, West Chester, PA, USAG.L. Russo, Avellino, ItalyK.S.M. Smalley, Tampa, FL, USAF. Takahashi-Yanaga, Fukuoka, JapanB.A. Teicher, Rockville, MD, USAK.D. Tew, Charleston, SC, USAG. Viola, Padova, ItalyJ. Wang, Shanghai, ChinaF. Zunino, Milan, Italy
Cardiovascular P. Anversa, Boston, MA, USAM.R. Bennett, Cambridge, UKY.-H. Feng, Bethesda, MD, USAD.J. Fitzgerald, Dublin, IrelandB.M. Frey-von Matt, Bern, SwitzerlandR.A. Khalil, W. Roxbury, MA, USAD. Newby, Edinburgh, UKF.G. Spinale, Columbia, SC, USAB. Staels, Lille, FranceR.J. Winquist, Cambridge, MA, USA
Metabolic Disorders and EndocrinologyN. Chattopadhyay, Uttar Pradesh, IndiaA. Kowluru, Detroit, MI, USAJ. Pierre, Villejuif, France
M.E. Poirot, Toulouse, FranceC.D. Sutherland, Dundee, UK
Inflammation & Immunopharmacology M.J. Alcaraz, Valencia, SpainR. Beyaert, Gent, BelgiumA. Bowie, Dublin, IrelandM. Burczynski, Pennington, NJ, USAF. D’Acquisto, London, UKJ. El Benna, Paris, FranceM.P. Fink, Los Angeles, CA, USAK.B. Glaser, Abbott Park, IL, USAJ.P. Hardwick, Rootstown, OH, USAJ.-H. Lai, Tao-Yuan, Taiwan, ROCO. Lèo, Gosselies, BelgiumK. McCoy, Richmond, VA, USAA. Miller, Haifa, IsraelJ.J. Moreno, Barcelona, SpainM. Mousli, Strasbourg, FranceM. Seavey, West Chester, PA, USAD.R. Webb, La Jolla, CA, USA
Neuropharmacology D.C. Bertrand, Genève, SwitzerlandB. Bettler, Basel, SwitzerlandR.A.J. Challiss, Leicester, UKC. Forray, Paramus, NJ, USAM.F. Jarvis, Abbott Park, IL, USAM.J. Kuhar, Atlanta, GA, USAR.J. Lewis, St Lucia, QLD, AustraliaM.J. Marino, West Point, PA, USAP. McGonigle, Tarrytown, NY, USAP.J. McLaughlin, Hershey, PA, USAH. Möhler, Zürich, SwitzerlandG. Perry, San Antonio, TX, USAR.D. Spealman, Southborough, MA, USAD.J. Triggle, Buffalo, NY, USAJ.M. Witkin, Indianapolis, IN, USA
Pharmacokinetics & Drug Metabolism J.R. Idle, Bern, SwitzerlandK.-I. Inui, Kyoto, JapanY. Kanai, Osaka, JapanI. de Lannoy, Ontario, CanadaH. Yamazaki, Tokyo, Japan
Toxicology K.W. Bock, Tübingen, GermanyB.J. Day, Denver, CO, USA
EDITORIAL ADVISORY BOARD
